Neil E. Stahl - 02 Feb 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Reporting relationship: EVP Research and Development
Issuer ticker: REGN
Reported as of: 02 Feb 2024
Net transaction value: -$9,438,846
SEC form: 4
Accepted by SEC: 06 Feb 2024, 16:08:32 UTC
Prior SEC filing: 12 Dec 2023
Next SEC filing: 08 Feb 2024
Source filing: View source filing
Reporting owner signature: /s/**Neil Stahl

Key filing fact

Neil E. Stahl filed Form 4 for REGENERON PHARMACEUTICALS, INC. (REGN) on 06 Feb 2024.

Key facts

This page summarizes Neil E. Stahl's Form 4 filing for REGENERON PHARMACEUTICALS, INC. (REGN).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 06 Feb 2024, 16:08.

Change

Previous filing in this sequence was filed on 12 Dec 2023.
Current net transaction value: -$9,438,846.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

REGN transaction

Common Stock

Options Exercise

Transaction value: $12,289,545
Shares: +30,750
Change %: +59%
Price: $399.66
Shares after: 82,769
Date: 02 Feb 2024
Ownership: Direct

REGN transaction

Common Stock

Tax liability

Transaction value: $21,728,391
Shares: -22,713
Change %: -27%
Price: $956.65
Shares after: 60,056
Date: 02 Feb 2024
Ownership: Direct

REGN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 5,834
Date: 02 Feb 2024
Ownership: By 401(k) Plan

REGN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 4,605
Date: 02 Feb 2024
Ownership: by Spouse as Trustee

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

REGN transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -30,750
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 02 Feb 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 30,750
Exercise price: $399.66
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock option award vests in four equal annual installments, commencing one year after the date of grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .